Spark's Gene Therapy Luxturna Sails Through US FDA Panel

 
• By Sue Sutter
  
Blind pedestrian walking and detecting markings on tactile paving with textured ground surface indicators for blind and visually impaired.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers